Global Reporting Initiative (GRI) Report

Overview

The report presents Ajanta Pharma's inaugural GRI disclosure for FY 2024-25 on a consolidated basis, covering Environment, Social and Governance efforts. It highlights 12.60 MW of installed solar capacity, 93% of waste recycled, 40K+ litres of water harvested at major sites, and three sites achieving Zero Discharge of Hazardous Waste. Governance is structured through a CSR and Sustainability Committee that reviews ESG initiatives quarterly and reports to the Board, which reviews performance annually.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024-2025
Period: 1 April 2024 – 31 March 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services